Position in ENTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$21,239
-$15,882 QoQ
Shares Held
19,135
0.0% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Gem Investment Advisors, LLC holds $16,930,567 across 6 Biotechnology names. ENTX ranks #6 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABSI |
Absci Corp
|
2,170,863 | $6,512,589 | |
| 2 | ORMP |
Oramed Pharmaceuticals Inc.
|
1,640,069 | $5,576,234 | |
| 3 | LRMR |
Larimar Therapeutics, Inc.
|
854,230 | $3,844,035 | |
| 4 | DRTS |
Alpha Tau Medical Ltd.
|
113,736 | $804,113 | |
| 5 | FTRE |
Fortrea Holdings Inc.
|
18,297 | $172,357 | |
| 6 | ENTX |
Entera Bio Ltd.
This page
|
19,135 | $21,239 |
All Filings in ENTX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,239 | 19,135 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $37,121 | 19,135 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||